Truist raised the firm’s price target on Cigna (CI) to $350 from $320 and keeps a Buy rating on the shares. The firm is adjusting its model after the company’s Q4 results and 2026 guidance, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CI:
- Cigna: Solid Execution but Uncertain PBM Economics Support Neutral Hold Rating and $300 Target
- Cigna price target raised to $304 from $301 at Deutsche Bank
- CVS, ELV, CNC: Health Insurer Stocks Under Pressure as U.S. Expands Fraud Probe
- Subpoenas issued to eight health insurers by House panel, Axios reports
- Cigna price target raised to $375 from $340 at UBS